Principal Investigator
Overview
Disorders and Conditions
Status
Recruiting
Start/End Dates
Locations
UBC Hospital
Name/Title
Zachary Allan, Study Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the efficacy of 25mg of psilocybin versus a placebo in subjects with alcohol use disorder through analysis of the number of heavy drinking days over the eight-week treatment period.
Eligibility
You may be eligible to participate in this study if you:
- have alcohol dependence and/or use alcohol almost daily in large amounts
- are between the ages of 18 and 70
- are generally healthy with no unstable medical conditions
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
Disorders and Conditions
Status
Recruiting
Start/End Dates
Locations
UBC Hospital
Name/Title
Zachary Allan, Study Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the efficacy of 25mg of psilocybin versus a placebo in subjects with alcohol use disorder through analysis of the number of heavy drinking days over the eight-week treatment period.
Eligibility
You may be eligible to participate in this study if you:
- have alcohol dependence and/or use alcohol almost daily in large amounts
- are between the ages of 18 and 70
- are generally healthy with no unstable medical conditions
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
